199 Digitization of multistep organic synthesis in reactionware for on-demand pharmaceuticals.

198 The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.

197 A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.

196 Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics.

195 Molecular basis of USP7 inhibition by selective small-molecule inhibitors.

194 Chemical synthesis yields gram quantities of a scarce compound under study for treating HIV, cancer, and Alzheimer’s disease.

193 Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.

192 Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents.

191 Plasmonic silver nanoshells for drug and metabolite detection.

190 Synergy of synthesis, computation and NMR reveals correct baulamycin structures.

189 Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.

188 A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism.

187 Click chemistry enables preclinical evaluation of targeted epigenetic therapies.

186 Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment.

185 A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.

184 Predictive compound accumulation rules yield a broad-spectrum antibiotic.

183 Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.

182 Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.

181 The druggable genome and support for target identification and validation in drug development.

180 Systemic delivery of factor IX messenger RNA for protein replacement therapy.

Free Images for Presentation: sunipix SUNIPIX